生命科学试剂
Search documents
优宁维:公司会密切关注AI智能等相关领域的发展动态
Zheng Quan Ri Bao· 2026-01-09 11:45
(文章来源:证券日报) 证券日报网讯 1月9日,优宁维在互动平台回答投资者提问时表示,公司会密切关注AI智能等相关领域 的发展动态,积极借助人工智能相关技术赋能公司业务发展和日常经营管理,不断提升公司业务能力和 经营效率。 ...
优宁维:公司高度关注股价波动
Zheng Quan Ri Bao Zhi Sheng· 2026-01-09 11:08
(编辑 楚丽君) 证券日报网讯 1月9日,优宁维在互动平台回答投资者提问时表示,公司高度关注股价波动。为提升投 资者信心,2024年至今,公司已推出两期股份回购计划,首期已实施完毕,使用25987076元(不包含交 易费用)回购927600股,首期回购股份计划用于股权激励或员工持股计划;第二期回购方案正在实施 中,最新的回购情况投资者可关注公司于月初发布的回购进展公告,本期回购的股份计划用于减少注册 资本。后续公司将会继续运用好股份回购、股权激励等工具,努力提升公司经营质量和业绩,更好地回 报投资者。 ...
优宁维12月24日获融资买入175.45万元,融资余额6336.41万元
Xin Lang Cai Jing· 2025-12-25 01:39
融资方面,优宁维当日融资买入175.45万元。当前融资余额6336.41万元,占流通市值的2.44%,融资余 额超过近一年90%分位水平,处于高位。 12月24日,优宁维涨0.60%,成交额1713.07万元。两融数据显示,当日优宁维获融资买入额175.45万 元,融资偿还146.69万元,融资净买入28.76万元。截至12月24日,优宁维融资融券余额合计6336.41万 元。 截至9月30日,优宁维股东户数9893.00,较上期减少13.19%;人均流通股5753股,较上期增加15.19%。 2025年1月-9月,优宁维实现营业收入7.76亿元,同比减少6.24%;归母净利润-1507.96万元,同比减少 207.11%。 分红方面,优宁维A股上市后累计派现1.82亿元。近三年,累计派现1.38亿元。 机构持仓方面,截止2025年9月30日,优宁维十大流通股东中,诺安多策略混合A(320016)位居第八 大流通股东,持股49.91万股,为新进股东。 责任编辑:小浪快报 融券方面,优宁维12月24日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00元; 融券余量0.00股,融券余额0. ...
优宁维12月23日获融资买入123.91万元,融资余额6307.64万元
Xin Lang Cai Jing· 2025-12-24 01:36
截至9月30日,优宁维股东户数9893.00,较上期减少13.19%;人均流通股5753股,较上期增加15.19%。 2025年1月-9月,优宁维实现营业收入7.76亿元,同比减少6.24%;归母净利润-1507.96万元,同比减少 207.11%。 分红方面,优宁维A股上市后累计派现1.82亿元。近三年,累计派现1.38亿元。 12月23日,优宁维跌0.17%,成交额1267.59万元。两融数据显示,当日优宁维获融资买入额123.91万 元,融资偿还83.96万元,融资净买入39.94万元。截至12月23日,优宁维融资融券余额合计6307.64万 元。 融资方面,优宁维当日融资买入123.91万元。当前融资余额6307.64万元,占流通市值的2.44%,融资余 额超过近一年90%分位水平,处于高位。 融券方面,优宁维12月23日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00元; 融券余量0.00股,融券余额0.00元,超过近一年90%分位水平,处于高位。 资料显示,上海优宁维生物科技股份有限公司位于上海市浦东新区古丹路15弄16号楼,成立日期2004年 10月22日,上市日期20 ...
优宁维:主要面向国内高等院校等科研端 提供生命科学试剂等产品和服务
Zheng Quan Ri Bao· 2025-12-19 15:20
(文章来源:证券日报) 证券日报网讯 12月19日,优宁维在互动平台回答投资者提问时表示,公司主要面向国内高等院校、科 研院所、医院和生物医药企业等科研端,提供生命科学试剂、设备、耗材、综合技术服务等产品和服 务。 ...
优宁维11月12日获融资买入342.82万元,融资余额5688.14万元
Xin Lang Cai Jing· 2025-11-13 01:40
Core Insights - The stock of Uningwei increased by 1.19% on November 12, with a trading volume of 51.13 million yuan [1] - The company experienced a net financing outflow of 2.28 million yuan on the same day, indicating a low financing balance compared to the past year [1] - Uningwei's main business includes providing life science reagents, instruments, and technical services, with a revenue composition heavily weighted towards life science reagents [1] Financing and Trading Data - On November 12, Uningwei had a financing buy-in amount of 3.43 million yuan and a financing repayment of 5.71 million yuan, resulting in a net financing buy of -2.28 million yuan [1] - The total financing and securities lending balance as of November 12 was 56.88 million yuan, accounting for 1.98% of the circulating market value, which is below the 50th percentile of the past year [1] - Uningwei had no securities lending activity on November 12, with a lending balance of 0.00 shares, indicating a high level of inactivity in this area [1] Financial Performance - For the period from January to September 2025, Uningwei reported a revenue of 776 million yuan, a year-on-year decrease of 6.24%, and a net profit attributable to shareholders of -15.08 million yuan, a significant decline of 207.11% [2] - As of September 30, 2025, the number of Uningwei's shareholders was 9,893, a decrease of 13.19% from the previous period, while the average circulating shares per person increased by 15.19% to 5,753 shares [2] Dividend and Shareholding Information - Since its A-share listing, Uningwei has distributed a total of 182 million yuan in dividends, with 138 million yuan distributed over the past three years [3] - As of September 30, 2025, the top ten circulating shareholders included a new shareholder, Nuoan Multi-Strategy Mixed A, holding 499,100 shares, ranking as the eighth largest circulating shareholder [3]
优宁维11月11日获融资买入330.19万元,融资余额5915.86万元
Xin Lang Cai Jing· 2025-11-12 01:36
Core Viewpoint - The company You Ning Wei has shown a mixed performance in terms of stock trading and financial results, with a notable decrease in revenue and net profit year-on-year, while maintaining a significant presence in the life sciences sector [1][2]. Group 1: Stock Performance - On November 11, You Ning Wei's stock rose by 1.27%, with a trading volume of 33.29 million yuan [1]. - The financing buy-in amount on the same day was 3.30 million yuan, while the financing repayment was 3.03 million yuan, resulting in a net financing buy of 0.28 million yuan [1]. - As of November 11, the total financing and securities balance was 59.16 million yuan, accounting for 2.08% of the market capitalization, indicating a high level compared to the past year [1]. Group 2: Financial Performance - For the period from January to September 2025, You Ning Wei reported a revenue of 776 million yuan, representing a year-on-year decrease of 6.24% [2]. - The net profit attributable to the parent company was -15.08 million yuan, reflecting a significant year-on-year decline of 207.11% [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for You Ning Wei was 9,893, a decrease of 13.19% from the previous period [2]. - The average number of circulating shares per person increased by 15.19% to 5,753 shares [2]. - The company has distributed a total of 182 million yuan in dividends since its A-share listing, with 138 million yuan distributed in the last three years [3].
优宁维11月6日获融资买入250.72万元,融资余额5833.40万元
Xin Lang Cai Jing· 2025-11-07 01:42
Core Viewpoint - The company You Ning Wei has shown a mixed performance in terms of stock trading and financial results, with a slight increase in stock price but a decline in revenue and net profit for the year-to-date period [1][2]. Group 1: Stock Performance - On November 6, You Ning Wei's stock price increased by 0.71%, with a trading volume of 25.51 million yuan [1]. - The financing buy-in amount on the same day was 2.51 million yuan, while the financing repayment was 2.12 million yuan, resulting in a net financing buy-in of 390,100 yuan [1]. - As of November 6, the total financing and securities lending balance was 58.33 million yuan, accounting for 2.06% of the circulating market value, indicating a relatively high level compared to the past year [1]. Group 2: Financial Performance - For the period from January to September 2025, You Ning Wei reported a revenue of 776 million yuan, representing a year-on-year decrease of 6.24% [2]. - The net profit attributable to the parent company was -15.08 million yuan, reflecting a significant year-on-year decline of 207.11% [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for You Ning Wei was 9,893, a decrease of 13.19% from the previous period [2]. - The average number of circulating shares per shareholder increased by 15.19% to 5,753 shares [2]. - The company has distributed a total of 182 million yuan in dividends since its A-share listing, with 138 million yuan distributed over the past three years [3].
优宁维:2025年前三季度净利润约-1508万元
Mei Ri Jing Ji Xin Wen· 2025-10-29 08:22
Company Performance - Youningwei (SZ 301166) reported Q3 performance on October 29, with revenue approximately 776 million yuan, a year-on-year decrease of 6.24% [1] - The net profit attributable to shareholders was a loss of approximately 15.08 million yuan, with basic earnings per share showing a loss of 0.17 yuan [1] - As of the report, Youningwei's market capitalization stands at 2.7 billion yuan [1] Industry Context - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation [1] - The technology sector is leading the market's transformation, indicating the emergence of a "slow bull" market pattern [1]
优宁维9月25日获融资买入218.48万元,融资余额6165.86万元
Xin Lang Cai Jing· 2025-09-26 01:36
Group 1 - The core viewpoint of the news is that You Ning Wei's stock performance and financial metrics indicate a challenging period, with a decline in revenue and net profit, while financing activities show a relatively high level of engagement [1][2]. Group 2 - On September 25, You Ning Wei's stock price fell by 1.17%, with a trading volume of 31.80 million yuan. The financing buy-in amount was 2.18 million yuan, while the financing repayment was 1.93 million yuan, resulting in a net financing buy of 250,600 yuan. The total financing and securities balance reached 61.66 million yuan [1]. - The financing balance of You Ning Wei is 61.66 million yuan, accounting for 2.34% of the circulating market value, which is above the 70th percentile level over the past year, indicating a high position [1]. - As of June 30, the number of shareholders of You Ning Wei increased to 11,400, a rise of 5.02%, with an average of 4,994 circulating shares per person, up by 31.33% [2]. - For the first half of 2025, You Ning Wei reported operating revenue of 505 million yuan, a year-on-year decrease of 8.63%, and a net profit attributable to shareholders of -13.38 million yuan, a year-on-year decrease of 188.64% [2]. - Since its A-share listing, You Ning Wei has distributed a total of 182 million yuan in dividends, with 138 million yuan distributed over the past three years [3].